Company: CWAN
Filing Date: 2025-01-13
Form Type: 425
Source: 0001104659-25-003010
Chunk: 14

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-01-13
Form: 425
Chunk 14
---
 or adjustments to the preliminary financial results presented herein,
as well as the Company’s or Clearwater’s response to any of the aforementioned factors. These risks, as well as other risks
related to the proposed transaction, will be included in the registration statement on Form S-4 and joint proxy/statement prospectus that
will be filed with the SEC in connection with the proposed transaction.

For information regarding other factors that could cause the Company’s
or Clearwater’s results to vary from expectations, please see the “Risk Factors” section of the Company’s and
Clearwater’s respective periodic report filings with the SEC, including but not limited to the Company’s and Clearwater’s
most recent Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K as well as other documents that may be filed by the Company
and by Clearwater from time to time with the SEC. While the list of factors presented here is, and the list of factors to be presented
in the registration statement on Form S-4 are, considered representative, no such list should be considered to be a complete statement
of all potential risks and uncertainties. The statements in this communication are made only as of the date hereof. Neither the Company
nor Clearwater undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by law.

Item 9.01 – Financial Statements and Exhibits.

(d) The following exhibits are being filed herewith:

| Exhibit No. 
 2.1         
 10.1        |     | Description                                                                                                                                                      
 Agreement and Plan of Merger, dated as of January 10, 2025, by and among Enfusion, Inc., the Operating Company, Parent, Acquirer, Merger Sub and Merger Sub II.* 
 Amendment No. 1 to Tax Receivable Agreement, dated as of January 10, 2025, by and among Enfusion, Inc. and the persons identified therein.*                      |
|:------------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 99.1        |     | Form of Support Agreement.                                                                                                                                       |
| 99.2        |     | Press Release of Enfusion, Inc. and Clearwater Analytics Holdings, Inc. issued on January 13, 2025.                                                              |
| 104         |     | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).                                                        |

*All schedules to